Patents by Inventor Eugene Izumchenko

Eugene Izumchenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TGF(?)-MIR200-MIG6 pathway and its use in the treatment of cancer as an indicator of resistance to EGFR inhibitors
    Patent number: 10801071
    Abstract: The present invention provides methods for identifying the susceptibility of a cancer cell or population of cells to treatment with Epidermal Growth Factor (EGF) Tyrosine Kinase Inhibitors (TKIs), such as erlotinib. Methods for the in vitro diagnosis of the susceptibility of a tumor in a subject to treatment with TKIs and monitoring tumor susceptibility during treatment are also provided.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: October 13, 2020
    Assignee: The Johns Hopkins University
    Inventors: David Sidransky, Eugene Izumchenko
  • THE TGF(Beta)-MIR200-MIG6 PATHWAY AND ITS USE IN THE TREATMENT OF CANCER AS AN INDICATOR OF RESISTANCE TO EGFR INHIBITORS
    Publication number: 20170175201
    Abstract: The present invention provides methods for identifying the susceptibility of a cancer cell or population of cells to treatment with Epidermal Growth Factor (EGF) Tyrosine Kinase Inhibitors (TKIs), such as erlotinib. Methods for the in vitro diagnosis of the susceptibility of a tumor in a subject to treatment with TKIs and monitoring tumor susceptibility during treatment are also provided.
    Type: Application
    Filed: April 22, 2015
    Publication date: June 22, 2017
    Inventors: David Sidransky, Eugene Izumchenko